Bristol Myers Squibb Executives
Bristol-Myers Squibb employs about 23.7 K people. The company is managed by 34 executives with a total tenure of roughly 289 years, averaging almost 8.0 years of service per executive, having 697.06 employees per reported executive. Discussion of Bristol-Myers Squibb's management performance can provide insight into the enterprise performance.
| Lamberto Andreotti CEO CEO, Director |
| Ann Powell President Chief Human Resource Officer, Senior Vice President |
Bristol-Myers |
Bristol-Myers Squibb Management Team Effectiveness
Bristol-Myers Squibb's management efficiency ratios could be used to measure how well Bristol-Myers Squibb manages its routine affairs as well as how well it operates its assets and liabilities.Bristol-Myers Squibb Workforce Comparison
Bristol Myers Squibb is number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers - Major industry is currently estimated at about 836,292. Bristol-Myers Squibb holds roughly 23,700 in number of employees claiming about 2.83% of equities under Drug Manufacturers - Major industry.
Bristol-Myers Squibb Notable Stakeholders
A Bristol-Myers Squibb stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bristol-Myers Squibb often face trade-offs trying to please all of them. Bristol-Myers Squibb's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bristol-Myers Squibb's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Lamberto Andreotti | CEO, Director | Profile | |
| Ann Powell | Chief Human Resource Officer, Senior Vice President | Profile | |
| Adam Dubow | Senior Vice President Chief Compliance Officer and Ethics Officer | Profile | |
| Charles Bancroft | CFO, Executive Vice President | Profile | |
| Louis Schmukler | President - Global Manufacturing and Supply | Profile | |
| Christopher Boerner | Executive Vice President and Chief Commercial Officer | Profile | |
| John Elicker | Senior Vice President - Public Affairs and Investor Relations | Profile | |
| Anne Nielsen | Senior Vice President Chief Compliance and Ethics Officer | Profile | |
| Karen Santiago | Senior Vice President Controller | Profile | |
| Emmanuel Blin | Senior Vice President Chief Strategy Officer | Profile | |
| Joseph Caldarella | Senior Vice President Corporate Controller | Profile | |
| Murdo Gordon | Executive Vice President Chief Commercial Officer | Profile | |
| Samuel Moed | Senior Vice President - Strategic Planning and Analysis | Profile | |
| Ann Judge | Senior Vice President - Global Human Resources | Profile | |
| Paul Autenried | Senior Vice President - Enterprise Services, CIO | Profile | |
| Francis Cuss | Executive Vice President Chief Scientific Officer | Profile | |
| Paul Biondi | Senior Vice President Head - Business Development | Profile | |
| Togo West | Independent Director | Profile | |
| Karen Vousden | Director | Profile | |
| Alan Lacy | Independent Director | Profile | |
| Robert Bertolini | Independent Director | Profile | |
| Jose Baselga | Independent Director | Profile | |
| Gerald Storch | Independent Director | Profile | |
| Michael Grobstein | Independent Director | Profile | |
| Giovanni Caforio | COO, Director | Profile | |
| Vicki Sato | Independent Director | Profile | |
| Laurie Glimcher | Independent Director | Profile | |
| Thomas Lynch | Independent Director | Profile | |
| Dinesh Paliwal | Independent Director | Profile | |
| Lewis Campbell | Independent Director | Profile | |
| Theodore Samuels | Independent Director | Profile | |
| Matthew Emmens | Independent Director | Profile | |
| Peter Arduini | Independent Director | Profile | |
| Sandra Leung | General Counsel, Corporate Secretary | Profile |
Bristol-Myers Squibb Workforce Analysis
Traditionally, organizations such as Bristol-Myers Squibb use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bristol-Myers Squibb within its industry.Bristol-Myers Squibb Manpower Efficiency
Return on Bristol-Myers Squibb Manpower
| Revenue Per Employee | 2M | |
| Revenue Per Executive | 1.4B | |
| Net Income Per Employee | 295.9K | |
| Net Income Per Executive | 206.3M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Bristol-Myers Pink Sheet
If you are still planning to invest in Bristol Myers Squibb check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bristol-Myers Squibb's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |